Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer
NCT ID: NCT05907265
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-05-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.
NCT07313709
Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
NCT06267014
Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
NCT04972019
VR-based Intervention for Cognitive Restoration
NCT05653596
Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer
NCT07335393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immersive Virtual Reality group
The intervention will be group-based, with 5 participants per group, and will consist of a total of 24 sessions of 60 minutes. These 24 sessions are organized over 12 weeks, 2 sessions per week. The sessions will consist of a group program of multimodal stimulation using immersive MK360 technology to train cognitive, emotional, and physical areas.
Each session will have a different content, although they will follow the following outline:
1. Welcome and awareness of the here and now.
2. Mindfulness techniques
3. Cognitive stimulation
4. Physical activation
5. Feedback and end of session.
The visual material used for each session will be specific and adapted to the group.
Behavioral: ONCOBrain_ImmersiveVR
A multimodal and digitally-based cognitive training, physical exercise and mindfulness intervention delivered face to face and through 360MK Virtual Reality technology
Active Comparator: Active control program
In paper or pdf format, patients in the active control group will receive guidelines for physical and cognitive stimulation to do autonomously at home. Patients in the active control group will receive guidelines for cognitive and physical stimulation and meditation exercises in paper or pdf format, to be done independently at home. They will be encouraged to do physical exercises, meditation, and cognitive activities two times a week.
Behavioral: Control_Condition
Traditional paper or pdf format multimodal intervention that will combine cognitive, mediation and physical activities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral: ONCOBrain_ImmersiveVR
A multimodal and digitally-based cognitive training, physical exercise and mindfulness intervention delivered face to face and through 360MK Virtual Reality technology
Behavioral: Control_Condition
Traditional paper or pdf format multimodal intervention that will combine cognitive, mediation and physical activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
B. Motor or sensory impairments that preclude completion of the program. C. Undergoing chemotherapy treatment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de Terrassa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maite Garolera
Principal Investigator of the Brain, Cognition, and Behavior Research Group (C3-CST)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consorci Sanitari de Terrassa
Terrassa, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01-22-107-107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.